Logo image of REX

REX AMERICAN RESOURCES CORP (REX) Stock Fundamental Analysis

NYSE:REX - New York Stock Exchange, Inc. - US7616241052 - Common Stock - Currency: USD

55.2  +1.17 (+2.17%)

After market: 55.2 0 (0%)

Fundamental Rating

6

REX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 210 industry peers in the Oil, Gas & Consumable Fuels industry. While REX has a great health rating, its profitability is only average at the moment. REX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

REX had positive earnings in the past year.
REX had a positive operating cash flow in the past year.
In the past 5 years REX has always been profitable.
Each year in the past 5 years REX had a positive operating cash flow.
REX Yearly Net Income VS EBIT VS OCF VS FCFREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 8.17%, REX is in the better half of the industry, outperforming 77.62% of the companies in the same industry.
With a decent Return On Equity value of 10.56%, REX is doing good in the industry, outperforming 62.38% of the companies in the same industry.
With a decent Return On Invested Capital value of 7.62%, REX is doing good in the industry, outperforming 64.76% of the companies in the same industry.
REX had an Average Return On Invested Capital over the past 3 years of 6.75%. This is significantly below the industry average of 23.80%.
The last Return On Invested Capital (7.62%) for REX is above the 3 year average (6.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.17%
ROE 10.56%
ROIC 7.62%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
REX Yearly ROA, ROE, ROICREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

REX has a Profit Margin (8.86%) which is in line with its industry peers.
In the last couple of years the Profit Margin of REX has grown nicely.
REX's Operating Margin of 10.07% is on the low side compared to the rest of the industry. REX is outperformed by 61.43% of its industry peers.
REX's Operating Margin has improved in the last couple of years.
REX has a worse Gross Margin (14.29%) than 68.57% of its industry peers.
In the last couple of years the Gross Margin of REX has grown nicely.
Industry RankSector Rank
OM 10.07%
PM (TTM) 8.86%
GM 14.29%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
REX Yearly Profit, Operating, Gross MarginsREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), REX is destroying value.
The number of shares outstanding for REX has been reduced compared to 1 year ago.
Compared to 5 years ago, REX has less shares outstanding
There is no outstanding debt for REX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
REX Yearly Shares OutstandingREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
REX Yearly Total Debt VS Total AssetsREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

An Altman-Z score of 6.86 indicates that REX is not in any danger for bankruptcy at the moment.
The Altman-Z score of REX (6.86) is better than 92.38% of its industry peers.
The Debt to FCF ratio of REX is 0.35, which is an excellent value as it means it would take REX, only 0.35 years of fcf income to pay off all of its debts.
REX has a Debt to FCF ratio of 0.35. This is amongst the best in the industry. REX outperforms 91.43% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that REX is not too dependend on debt financing.
The Debt to Equity ratio of REX (0.01) is better than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.35
Altman-Z 6.86
ROIC/WACC0.82
WACC9.29%
REX Yearly LT Debt VS Equity VS FCFREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

REX has a Current Ratio of 9.37. This indicates that REX is financially healthy and has no problem in meeting its short term obligations.
REX has a better Current ratio (9.37) than 96.19% of its industry peers.
A Quick Ratio of 8.65 indicates that REX has no problem at all paying its short term obligations.
REX's Quick ratio of 8.65 is amongst the best of the industry. REX outperforms 96.19% of its industry peers.
Industry RankSector Rank
Current Ratio 9.37
Quick Ratio 8.65
REX Yearly Current Assets VS Current LiabilitesREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

4

3. Growth

3.1 Past

REX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.19%.
REX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 54.06% yearly.
The Revenue for REX has decreased by -18.20% in the past year. This is quite bad
The Revenue has been growing by 8.99% on average over the past years. This is quite good.
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y54.06%
EPS Q2Q%-11.2%
Revenue 1Y (TTM)-18.2%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%-1.79%

3.2 Future

Based on estimates for the next years, REX will show a decrease in Earnings Per Share. The EPS will decrease by -4.03% on average per year.
The Revenue is expected to grow by 10.00% on average over the next years. This is quite good.
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
REX Yearly Revenue VS EstimatesREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
REX Yearly EPS VS EstimatesREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.78, which indicates a correct valuation of REX.
Compared to the rest of the industry, the Price/Earnings ratio of REX is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.69. REX is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 18.22 indicates a rather expensive valuation of REX.
REX's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.36, REX is valued rather cheaply.
Industry RankSector Rank
PE 16.78
Fwd PE 18.22
REX Price Earnings VS Forward Price EarningsREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, REX is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as REX.
Industry RankSector Rank
P/FCF 94.77
EV/EBITDA 5.08
REX Per share dataREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The decent profitability rating of REX may justify a higher PE ratio.
A cheap valuation may be justified as REX's earnings are expected to decrease with -4.03% in the coming years.
PEG (NY)N/A
PEG (5Y)0.31
EPS Next 2Y-4.03%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for REX!.
Industry RankSector Rank
Dividend Yield N/A

REX AMERICAN RESOURCES CORP

NYSE:REX (7/23/2025, 8:04:00 PM)

After market: 55.2 0 (0%)

55.2

+1.17 (+2.17%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-20 2025-05-20/bmo
Earnings (Next)08-25 2025-08-25/bmo
Inst Owners88.7%
Inst Owner Change-0.06%
Ins Owners14.04%
Ins Owner Change10.4%
Market Cap909.14M
Analysts80
Price Target51 (-7.61%)
Short Float %3.32%
Short Ratio4.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.29%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)3.38%
Revenue beat(4)2
Avg Revenue beat(4)2.08%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)9.23%
Revenue beat(8)4
Avg Revenue beat(8)2.04%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)10
Avg Revenue beat(16)2.8%
PT rev (1m)0%
PT rev (3m)-12.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.78
Fwd PE 18.22
P/S 1.42
P/FCF 94.77
P/OCF 14.44
P/B 1.69
P/tB 1.69
EV/EBITDA 5.08
EPS(TTM)3.29
EY5.96%
EPS(NY)3.03
Fwd EY5.49%
FCF(TTM)0.58
FCFY1.06%
OCF(TTM)3.82
OCFY6.93%
SpS38.83
BVpS32.57
TBVpS32.57
PEG (NY)N/A
PEG (5Y)0.31
Profitability
Industry RankSector Rank
ROA 8.17%
ROE 10.56%
ROCE 9.89%
ROIC 7.62%
ROICexc 14.79%
ROICexgc 14.79%
OM 10.07%
PM (TTM) 8.86%
GM 14.29%
FCFM 1.5%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
ROICexc(3y)16.25%
ROICexc(5y)14.31%
ROICexgc(3y)16.25%
ROICexgc(5y)14.31%
ROCE(3y)8.77%
ROCE(5y)8.17%
ROICexcg growth 3Y-10.04%
ROICexcg growth 5Y127.29%
ROICexc growth 3Y-10.04%
ROICexc growth 5Y127.29%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
F-Score5
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.35
Debt/EBITDA 0.03
Cap/Depr 239.19%
Cap/Sales 8.35%
Interest Coverage 250
Cash Conversion 72.63%
Profit Quality 16.93%
Current Ratio 9.37
Quick Ratio 8.65
Altman-Z 6.86
F-Score5
WACC9.29%
ROIC/WACC0.82
Cap/Depr(3y)192.86%
Cap/Depr(5y)131.33%
Cap/Sales(3y)5.81%
Cap/Sales(5y)4.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y54.06%
EPS Q2Q%-11.2%
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.2%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%-1.79%
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.53%
EBIT growth 3Y-2.54%
EBIT growth 5Y134.95%
EBIT Next Year3.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-77.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.83%
OCF growth 3Y-11.21%
OCF growth 5Y44.19%